Canada markets open in 8 hours 3 minutes

Seres Therapeutics, Inc. (1S9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.9728+0.0600 (+6.57%)
At close: 04:02PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 150.61M
Enterprise Value 277.66M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)377.58
Price/Book (mrq)67.04
Enterprise Value/Revenue 826.24
Enterprise Value/EBITDA -1.98

Trading Information

Stock Price History

Beta (5Y Monthly) 2.01
52-Week Change 3-62.89%
S&P500 52-Week Change 329.75%
52 Week High 32.5000
52 Week Low 30.5302
50-Day Moving Average 30.9295
200-Day Moving Average 30.8976

Share Statistics

Avg Vol (3 month) 343
Avg Vol (10 day) 3N/A
Shares Outstanding 5152.38M
Implied Shares Outstanding 6165M
Float 8120.2M
% Held by Insiders 15.44%
% Held by Institutions 145.42%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-42,211.23%

Management Effectiveness

Return on Assets (ttm)-27.10%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)374k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -151.58M
Net Income Avi to Common (ttm)-162.1M
Diluted EPS (ttm)-1.0700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.23M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)212.62M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.38
Book Value Per Share (mrq)-0.57

Cash Flow Statement

Operating Cash Flow (ttm)-181.8M
Levered Free Cash Flow (ttm)-98.53M